KYAN Therapeutics vs Owl Therapeutics

KYAN Therapeutics logo

KYAN Therapeutics

Advanced AI for Faster, Safer Drug Development and Optimized Therapies

2-10 employees · est. 2014

VS
Owl Therapeutics logo

Owl Therapeutics

Unlocking Wisdom for Brain Health

2 employees · est. 2023 · San Antonio, United States

KYAN Therapeutics is the older company (2014 vs 2023).

Side-by-Side Comparison

KYAN Therapeutics Owl Therapeutics
Founded
2014 older 2023
Headquarters
Not tracked yet San Antonio, United States
Employees
2-10 2
Industry
AI, Biopharma, Biotechnology Biopharma
Funding Stage
Seed Not tracked yet
Total Funding
$5.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Domain parking and registration Not tracked yet
Target Customers
Businesses seeking to park or register domain names Not tracked yet
Taxonomy
Advanced AIDrug DevelopmentDosage OptimizationProprietary TechnologyCombination TherapiesOncology +8 Owl TherapeuticsGryphon BioBiopharmaceutical CompanyClinical-stageTherapeuticsTraumatic Brain Injury +4
Website
kyantherapeutics.com owltherapeutics.com
KYAN Therapeutics logo

About KYAN Therapeutics

KYAN Therapeutics, established in 2014, is a clinical-stage company at the intersection of AI and biopharma, focused on revolutionizing drug development through its proprietary artificial intelligence technology. The company aims to optimize therapy protocols, significantly accelerating the developm...

Owl Therapeutics logo

About Owl Therapeutics

Owl Therapeutics is a wholly-owned subsidiary of Gryphon Bio​ that is dedicated to unlocking wisdom for brain health. Specializing in the development of diagnostic-powered therapeutics for traumatic brain injury (TBI) and brain health, Owl Therapeutics has rapidly constructed a diversified pipeline...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches KYAN Therapeutics and Owl Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when KYAN Therapeutics or Owl Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

KYAN Therapeutics was founded in 2014, with 2-10 employees. KYAN Therapeutics, established in 2014, is a clinical-stage company at the intersection of AI and biopharma, focused on revolutionizing drug development through its proprietary artificial intelligence. Owl Therapeutics was founded in 2023, based in San Antonio, United States, with 2 employees. Owl Therapeutics is a wholly-owned subsidiary of Gryphon Bio​ that is dedicated to unlocking wisdom for brain health. Specializing in the development of diagnostic-powered therapeutics for traumatic b.
KYAN Therapeutics has raised $5.00M and Owl Therapeutics no disclosed funding. Latest stage: KYAN Therapeutics Seed.
Both work in Biopharma and list drug development among their focus areas.

Compare KYAN Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at KYAN Therapeutics on 15 Jun 2026, and Owl Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes